Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Five Prime Therapeutics, Inc. (FPRX)

« Back to company index

FPRX Chatter Timeline

Stock Ticker for FPRX

Most Active Tweeters for FPRX

UserTweets
@YuZhu4 4
@Tickeron 4
@innersigma 4
@intratio 3
@anticancervibe 3

Recent Tweets for FPRX

YuZhu4 @YuZhu4
RT @hemonctrader: $FPRX Undervalued IMHO. GI ASCO Ph2 data in 1st line combo with FOLFOX for FGFR2b(30%) is impressive. Mono activity. Plan…
January 18th 2021, 9:01pm
kwhenfinance @kwhenfinance
Five Prime Therapeutics Inc. Shares Close the Day 10.9% Lower - Daily Wrap https://t.co/vdtP0kckw0 $FPRX #stockmarket #kwhenfinance
January 17th 2021, 8:01pm
hemonctrader @hemonctrader
$FPRX Undervalued IMHO. GI ASCO Ph2 data in 1st line combo with FOLFOX for FGFR2b(30%) is impressive. Mono activity… https://t.co/GzKBvNt3wS
January 17th 2021, 3:01pm
anticancervibe @anticancervibe
@bigpharmaguy @OxAnalyst $FPRX did the same at GI ASCO with p value of 0.07 and it was an oral :)
January 17th 2021, 4:01am
NotthatkindofDr @NotthatkindofDr
An interesting note that I missed from $FPRX data: they do appear to have a reliable biomarker in their FGFR2-IHC.… https://t.co/LLJlwWBS6u
January 16th 2021, 7:01pm
kwhenfinance @kwhenfinance
Five Prime Therapeutics Inc. Shares Close the Day 10.9% Lower - Daily Wrap https://t.co/llhSr4po3O $FPRX #stockmarket #kwhenfinance
January 16th 2021, 12:01pm
Gambiste1 @Gambiste1
RT @anticancervibe: $FPRX Can anyone explain how the FIGHT trial met statistical significance with a p value > 0.05 ? The primary endpoin…
January 16th 2021, 4:01am
Alexand76592800 @Alexand76592800
*Another great week! Gains of over 2400% and over 18% returns!! A big thank you to this community.* $PT $FPRX… https://t.co/oWR0VsRy7K
January 16th 2021, 3:01am
anticancervibe @anticancervibe
$FPRX Can anyone explain how the FIGHT trial met statistical significance with a p value > 0.05 ? The primary end… https://t.co/hFfutYH2Tp
January 16th 2021, 2:01am
SeekingAlpha @SeekingAlpha
$FPRX - Five Prime Therapeutics (FPRX) Presents at ASCO Gastrointestinal Cancer Symposium 2021 - Slideshow.… https://t.co/kDD6my9bhC
January 15th 2021, 10:01pm
StockTexts @StockTexts
$FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/ldtbtJHf7D
January 15th 2021, 10:01pm
EdgarInsider @EdgarInsider
Filing Alert, FORM 8-K [Press/News Current Report] available. $FPRX FIVE PRIME THERAPEUTICS, INC https://t.co/K1zFw1xqyh
January 15th 2021, 10:01pm
fintel_io @fintel_io
$FPRX / Five Prime Therapeutics files form 8-K - Results of Operations and Financial Condition - 8-K https://t.co/b4OMb36Sf9
January 15th 2021, 10:01pm
FlashAlert_me @FlashAlert_me
$FPRX [15s. delayed] filed form 8-K on January 15, 17:00:53: Item2.02: Results of Operations & Financial Condition https://t.co/inS2VAbrxo
January 15th 2021, 10:01pm
goldmask123 @goldmask123
RT @_B_I_O_T_E_C_H_: $FPRX FIVE PRIME THERAPEUTICS INC - ALL THREE EFFICACY ENDPOINTS (PFS, OS AND ORR) IN FIGHT PHASE 2 TRIAL MET PRE-SPEC…
January 15th 2021, 9:01pm
innersigma @innersigma
03:58:23 PM DREV Automated Exit. Closing my $FPRX position of 1765 shares that was opened today for a 0.45% gain.
January 15th 2021, 9:01pm
MarketChmln @MarketChmln
$FPRX stock declines -10.4%. View latest news. https://t.co/zJkmJ1ETVg
January 15th 2021, 9:01pm
Ezehtim @Ezehtim
$FPRX bought heavy now
January 15th 2021, 4:01pm
innersigma @innersigma
11:00:35 AM DREV Automated Entry. Long 1766 shares of $FPRX at 14.16 for a trade that I will be looking to close today.
January 15th 2021, 4:01pm
MarcJacksonLA @MarcJacksonLA
$FPRX Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce P… https://t.co/hZSI9KplT6
January 15th 2021, 3:01pm
StockTexts @StockTexts
$FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/9zqEkvm8Tu
January 15th 2021, 3:01pm
EdgarInsider @EdgarInsider
Filing Alert, FORM 8-K [Press/News Current Report] available. $FPRX FIVE PRIME THERAPEUTICS, INC. FIVE PRIME THER… https://t.co/Q4s1fJWn0O
January 15th 2021, 3:01pm
FlashAlert_me @FlashAlert_me
$FPRX [15s. delayed] filed form 8-K on January 15, 10:06:39: Item8.01: Other Material Events https://t.co/GrE3874sGZ
January 15th 2021, 3:01pm
StockPlays @StockPlays
$FPRX Five Prime Therapeutics Phase 2 trial met all three efficacy endpoints and demonstrated statistically signifi… https://t.co/XABSs0MhrJ
January 15th 2021, 2:01pm
Briefingcom @Briefingcom
$FPRX: Five Prime Therapeutics reports Phase 2 FIGHT trial results presented at ASCO GI that validate importance of… https://t.co/fc5XLw6OTp
January 15th 2021, 1:01pm
IOInvestors @IOInvestors
$FPRX +16.5% (reports Phase 2 FIGHT trial results presented at ASCO GI that validate importance of FGFR2b overexpre… https://t.co/Dim3iIyudL
January 15th 2021, 1:01pm
MarketChmln @MarketChmln
$FPRX gains in premarket trading. See the latest news. https://t.co/coYu1gm2Fb https://t.co/rlFGc3Q8xy
January 15th 2021, 1:01pm
NewsQuantified @NewsQuantified
$FPRX announced clinical results from the global, randomized, double-blind placebo-controlled Phase 2 FIGHT trial e… https://t.co/BkvQfzE2yN
January 15th 2021, 1:01pm
StckPro @StckPro
$FPRX NEW ARTICLE : Five Prime's bemarituzumab shows PFS benefit in mid-stage gastric cancer study… https://t.co/vVjwn2gUfa
January 15th 2021, 12:01pm
MarketCurrents @MarketCurrents
$FPRX - Five Prime's bemarituzumab shows PFS benefit in mid-stage gastric cancer study https://t.co/f6brJc2Rwr
January 15th 2021, 12:01pm
BankTheTrade @BankTheTrade
$FPRX(15.96) up 3.75 announced clinical results from the global, randomized, double-blind placebo-controlled Phase… https://t.co/2qLXHNGdnl
January 15th 2021, 12:01pm
TeamofStockTra @TeamofStockTra
$FPRX - Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce… https://t.co/z3MGstNGfb
January 15th 2021, 12:01pm
sbwcws @sbwcws
Five Prime says Phase 2 FIGHT trial met all three efficacy endpoints $FPRX
January 15th 2021, 12:01pm
JanEhses @JanEhses
Slides of the full dataset of the FIGHT phase 2 trial now available. $FPRX https://t.co/hqQLWkD2Ew
January 15th 2021, 12:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$FPRX FIVE PRIME THERAPEUTICS INC - ALL THREE EFFICACY ENDPOINTS (PFS, OS AND ORR) IN FIGHT PHASE 2 TRIAL MET PRE-S… https://t.co/KEej9dkCKS
January 15th 2021, 12:01pm
stock_titan @stock_titan
$FPRX Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce P… https://t.co/SvhRXHYiPx
January 15th 2021, 11:01am
innersigma @innersigma
03:58:10 PM DREV Automated Exit. Closing my $FPRX position of 1721 shares that was opened today for a 2.99% gain.
January 13th 2021, 9:01pm
TradeWithAlerts @TradeWithAlerts
Large Print $FPRX Size: 125679 Price: 15 Time: 1453 Amount: $1,885,185.00
January 13th 2021, 7:01pm
YuZhu4 @YuZhu4
RT @Fallenfloweronw: $FPRX has been going down into the ASCO presentation this Friday. Word is that they have nothing new, since the Novemb…
January 13th 2021, 7:01pm
YuZhu4 @YuZhu4
RT @Santabanta84: @MSollender $FPRX Grade =3 AEs ( 83% on bema vs 74% on pbo), serious AEs in 32% and 36% respectively. Stomatitis highe…
January 13th 2021, 7:01pm
YuZhu4 @YuZhu4
RT @anticancervibe: @svarre001 What do you think of $FPRX data in ASCO GI ? median PFS of 9.5 mo (bema) vs 7.4 mo (pbo) (hazard ratio […
January 13th 2021, 7:01pm
NotthatkindofDr @NotthatkindofDr
Doing a little profit taking today and buying. Trimming around my core $CTMX position, $FPRX hit my 17 stop & broke… https://t.co/wpGDYL9XE0
January 13th 2021, 6:01pm
anticancervibe @anticancervibe
@svarre001 What do you think of $FPRX data in ASCO GI ? median PFS of 9.5 mo (bema) vs 7.4 mo (pbo) (hazard rat… https://t.co/a1zU69qtQG
January 13th 2021, 6:01pm
innersigma @innersigma
01:16:09 PM DREV Automated Entry. Long 1721 shares of $FPRX at 14.53 for a trade that I will be looking to close today.
January 13th 2021, 6:01pm
SdO7 @SdO7
$FPRX Perfect candidate for a multibillion partnering deal with BP… ACCUMULATE
January 13th 2021, 3:01pm
Fallenfloweronw @Fallenfloweronw
$FPRX has been going down into the ASCO presentation this Friday. Word is that they have nothing new, since the November data, to report
January 13th 2021, 3:01pm
intratio @intratio
$FPRX https://t.co/Bf3tPh3MwR Five Prime Therapeutics Inc The algorithm estimates this stock s value won t see its… https://t.co/3nz9KCENt4
January 13th 2021, 12:01am
sbwcws @sbwcws
Five Prime to hold a conference call $FPRX
January 12th 2021, 4:01pm
MarcJacksonLA @MarcJacksonLA
$FPRX $BMY Laryngeal Cancer Survivor Credits Phase 1 Trial For Lifesaving Results https://t.co/rztdLjJON0
January 12th 2021, 1:01pm
zbiotech @zbiotech
RT @MSollender: $FPRX ASCO GI abstract, more detailed Ph2 bemarituzumab data AE profile: Stomatitis was higher in the bema arm (31.6% vs…
January 12th 2021, 4:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.